
The Surprising Strategy Behind Context Therapeutics’ Stock Option Splash
Context Therapeutics is leveraging stock options as a key strategy to attract top talent crucial for its innovative biopharmaceutical projects. The Philadelphia-based company focuses on T cell engaging (TCE) bispecific antibodies, with promising candidates like CTIM-76 and CT-95 aimed at revolutionizing solid